Phenolic composition and correlation with antioxidant properties of various organic fractions from Hertia cheirifolia extracts.

Hertia cheirifolia L. is a medicinal plant that has been used for a long time in folk Mediterranean medicine. The aim of the present study was to analyze and compare the phenolic profile and the antioxidant potential of organic fractions from H. cheirifolia extracts. Crude methanolic extracts were firstly prepared from the different parts of the plant. Then four different organic fractions were obtained by fractioning each extract, using different solvents with increasing polarity (hexane, chloroform, and ethyl acetate). The Phenolic content was analyzed using a UV-Vis colorimetric methods followed by a qualitative and quantitative analysis by high performance liquid chromatography-diode array detector (HPLC-DAD) system. After that, the antioxidant potential of the different organic fractions was evaluated using DPPH and ABTS free radical scavenging assays, reducing power of iron (FRAP) and inhibition of ß-carotene oxidation tests. Our results revealed that ethyl acetate fractions (EA) contained the highest content of total phenolics (100-250 mg GAE/g). Indeed, the ethyl acetate fraction from the flower extract (EA-F) displayed the lowest IC50 values for the scavenging of DPPH and ABTS free radicals (38.83 ± 0.34 µg/ml and 23.76 ± 0.11 µg/ml, respectively). Also, the strongest iron reducing power (2628.87 ± 16.47 µmol Fe2+Eq/ml) and the best rate of inhibition of the ß-carotene oxidation (58.91 ± 5.79 %) were recorded. In sum, the present study suggests that, the organic fractions from H. cherifolia are potential natural antioxidants and this is probably related to their phenolics content and structure.

Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis.

The etiology of inflammatory bowel diseases which include ulcerative colitis (UC) and Crohn disease has not yet been clarified. Several hypotheses suggest a change in composition of gut microflora along with an impaired mucosal barrier that lead to excessive mucosal immunologic responses. Increased production of nitric oxide (NO) contributes greatly to the tissue injury caused by chronic inflammation. Evidence indicates that the mucus layer covering the epithelium is altered during UC and experimental colitis. Our aim in this study was to investigate the potential therapeutic effect of probiotic during DSS-induced colitis by modulating the immune system and colonic mucus production. For that purpose, the probiotic formulation Ultrabiotique(®) (Lactobacillus acidophilus, Bifidobacterium lactis, Lactobacillus plantarum and Bifidobacterium breve) was administered daily for 7 d to mice with colitis. Probiotic supplementation improved clinical symptoms and histological alterations observed during DSS induced colitis. Ultrabiotique(®) treatment down regulated the NO production by peritoneal macrophages of DSS-treated mice and enhanced mucus production in both DSS-treated and healthy mice. In conclusion, the modification of microflora by the Ultrabiotique(®) played a beneficial role in maintaining the integrity of the intestinal mucosal barrier and promoted tissue repair.

Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: effect of probiotics and prebiotics.

Inflammatory bowel disease (IBD) consists mainly of Ulcerative colitis (UC) and Crohn disease (CD). Although its aetiology is still not clearly established, it is thought to be due to overly aggressive immune response to enteric bacteria in genetically predisposed individuals. Manipulating the microbiota using probiotics or prebiotics is considered as a promising field of new therapeutic strategies used to attenuate immune disorders observed during IBD. The production of nitric oxide (NO) seems to be implicated in IBD pathogenesis. In our study, an acute UC was induced in Swiss mice using 3% Dextran Sulfate Sodium (DSS). The preventive effects of "Ultrabiotique®" (a probiotic) and inulin (a prebiotic) on the colitis were investigated. The production of NO was evaluated in the supernatants of peritoneal macrophages (pMφ) cultures. Colonic mucosa histology was subsequently examined. Results showed severe acute UC after administration of DSS. High levels of NO in pMφ cultures were also observed compared to control samples. These findings correlated with a significant destruction of the colonic mucosa. Oral administration of Ultrabiotique® or inulin decreased the severity of DSS-induced colitis. These treatments lead to a decrease in NO levels in pMφ cultures. A considerable reduction of colonic lesions was also noticed. Our findings suggest the involvement of NO in experimental UC pathogenesis. Pre- and pro-biotics, as discussed herein, seem to have an anti-inflammatory effect.